Nicholas Donoghoe
Fortuna: 19 M $ al 30/06/2026
Fortuna: 19 M $ al 30/06/2026
Nicholas J.
Donoghoe is currently Executive VP, Chief Business & Strategy Officer at AbbVie, Inc., a position held since 2019.
Formerly, Dr. Donoghoe was a Partner at McKinsey & Co., Inc. Dr. Donoghoe earned a doctorate from The Johns Hopkins University School of Medicine.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ABBVIE, INC. 0 % | 27/02/2026 | 74.430 ( 0 % ) | 19 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ABBVIE INC. | Corporate Officer/Principal | 01/01/2019 |
| Empresas | Cargo | Fin |
|---|---|---|
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
AbbVie, Inc.
AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
The Johns Hopkins University School of Medicine
The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.